U.S. to resume use of Johnson & Johnson COVID-19 vaccine

Go to the profile of Kayal
1 min read
By Kayal
U.S. to resume use of Johnson & Johnson COVID-19 vaccine
The United States will resume use of Johnson & Johnson's COVID-19 vaccine, top health regulators said on Friday, ending a 10-day pause to investigate the vaccine's link to extremely rare but potentially deadly blood clots.
world
Prev article
Canadians over 30 should be offered AstraZeneca-Oxford COVID-19 vaccine, advisory body recommends
Next article
PM's chief adviser knew of 'misconduct' allegation against top military commander, committee told
Share Tweet Send
0 Comments
Loading...

Related Articles

No results found
↑ ↓ Navigate up/down
Enter Go to article
/ Search new term
Esc Close search